JPRN-jRCT2080222826未知1 期
An open-label, single-sequence crossover study of DS-8500a to evaluate the effects on the pharmacokinetics of atorvastatin in Japanese healthy subjects
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 28 人开始时间: 2015年4月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 40age old（—）
- 性别
- All
入选标准
- •1. Japanese
- •2. Between the age of 20 and 40
- •3. Between the BMI of 18.5 and 25.0
- •4. HbA1c < 6.5%
- •5. Fasting blood glucose level within the reference range of a site
排除标准
- •1. Presence or history of hypersensitivity or idiosyncratic reaction (penicillin allergy etc,) to a drug including atorvastatin.
- •2. Presence or history of drug or alcohol dependence. etc.
研究者
相似试验
进行中（未招募）
1 期
An Open-label, One-sequence Crossover Study of Favipiravir to Evaluate the Effects on the Pharmacokinetics of Triazolam/Metformin Hydrochloride in Healthy Adult Subjectssevere fever with thrombocytopenia syndromeJPRN-jRCT2031220735Sakurai Tsutomu24
招募中
Unknown
A single-center open-label crossover study of the clinical utility and safety of the BV-UFC system of the DCS-200Si dialysis monitorPatients undergoing hemodialysishemodialysisD006435JPRN-jRCT1062230034Hamada Shintaro20
已完成
1 期
An Open-label, One-sequence Crossover Study of Solithromycin to Evaluate the Effects on the Pharmacokinetics of Rosuvastatin Calcium in Healthy Adult Subjects-JPRN-jRCT2080224614FUJIFILM Toyama Chemical Co., Ltd.14
已完成
1 期
An Open-label, One-sequence Crossover Study of Solithromycin to Evaluate the Effects on the Pharmacokinetics of Metformin Hydrochloride in Healthy Adult Subjects-JPRN-jRCT2080224615FUJIFILM Toyama Chemical Co., Ltd.14
已完成
1 期
A study of the safety and tolerability of single doses of wafers containing cannabidiol (CBD) that dissolve under the tongue compared to CBD oil that is swallowed in healthy volunteers.PainTremorInflammatory ConditionsAlternative and Complementary Medicine - Other alternative and complementary medicineInsomniaAnxietyACTRN12620000891921iX Biopharma Pty Ltd12